What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Healthcare Industry News Valar Labs’ AI biomarkers validated in European Urology as superior risk predictors for bladder cancer Valar Labs’ CHAI biomarkers validated in European Urology outperform standard methods in predicting outcomes for high grade Ta bladder cancer. bySoujanya RaviJune 13, 2025